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ABSTRACT
Homologous recombination (HR) plays a vital role in
DNA metabolic processes including meiosis, DNA
repair, DNA replication and rDNA homeostasis. HR
defects can lead to pathological outcomes,
including genetic diseases and cancer. Recent
studies suggest that the post-translational modifi-
cation by the small ubiquitin-like modifier (SUMO)
protein plays an important role in mitotic and
meiotic recombination. However, the precise role
of SUMOylation during recombination is still
unclear. Here, we characterize the effect of
SUMOylation on the biochemical properties of the
Saccharomyces cerevisiae recombination mediator
protein Rad52. Interestingly, Rad52 SUMOylation is
enhanced by single-stranded DNA, and we show
that SUMOylation of Rad52 also inhibits its DNA
binding and annealing activities. The biochemical
effects of SUMO modification in vitro are
accompanied by a shorter duration of spontaneous
Rad52 foci in vivo and a shift in spontaneous mitotic
recombination from single-strand annealing to gene
conversion events in the SUMO-deficient Rad52
mutants. Taken together, our results highlight the
importance of Rad52 SUMOylation as part of a
‘quality control’ mechanism regulating the efficiency
of recombination and DNA repair.
INTRODUCTION
DNA double-strand breaks (DSBs) are one of the most
toxic kinds of chromosome damage that are implicated
in cancer and many other diseases. A single unrepaired
break can lead to aneuploidy, genetic aberrations or
cell death. DSBs are caused by a vast number of
endogenous and exogenous agents including genotoxic
chemicals or ionizing radiation, as well as through repli-
cation of a damaged DNA template or replication fork
collapse. In the yeast Saccharomyces cerevisiae, homolo-
gous recombination (HR) is the major pathway for repair
of DSBs (1).
Genes of the RAD52 epistasis group mediate HR. The
members of this gene group were identiﬁed by mutants’
sensitivity to ionizing radiation or their deﬁciency in DSB
repair, and they include RAD50,RAD51, RAD52, RAD54,
RAD55, RAD57, RAD59, RDH54/TID1, MRE11 and
XRS2. These genes are also needed for HR and chromo-
some segregation in meiosis I and are in general highly
conserved among eukaryotes (2,3).
HR involves DNA homology search and DNA strand
invasion to form a joint between the recombining DNA
molecules. These reaction steps are mediated by the
Rad51 recombinase, an orthologue of the Escherichia
coli RecA recombinase (4). In the presence of ATP,
Rad51 binds single-stranded DNA (ssDNA) and forms a
right-handed ﬁlament called the presynaptic ﬁlament.
Since the assembly of the presynaptic ﬁlament proceeds
rather slowly, it is prone to interference by other
competing factors such as replication protein A (RPA)
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with a complex role in HR. In vitro, it was shown that
RPA stimulates recombination by eliminating secondary
structures in ssDNA and stabilizing the displaced strand
of the D-loop. However, due to its very high aﬃnity for
ssDNA, it can prevent Rad51 from binding ssDNA, thus
leading to the inhibition of presynaptic ﬁlament formation
(7). This inhibitory eﬀect can be overcome by the recom-
bination mediator activity of Rad52 (1).
Rad52 multimerizes and forms a ring structure (8). The
assembly of a ring structure requires sequences in the evo-
lutionary conserved N-terminal domain of Rad52, which
also possesses a DNA binding activity with a preference
for ssDNA (9). Yeast Rad52 can interact with Rad51 as
well as with RPA to help ensure the eﬃcient displacement
of RPA from ssDNA by Rad51 (10–12). The interaction
with RPA is mediated by a domain within the middle
portion of Rad52, while the carboxyl terminus harbours
the Rad51 interaction domain (13,14). Moreover, the
C-terminal domain also possesses a DNA binding
activity and alone has recombination mediator activity
(5). A robust DNA annealing activity has been described
for Rad52 as well (9).
Many proteins participating in HR can be
post-translationally modiﬁed by the small ubiquitin-like
modiﬁer (SUMO) protein, and this modiﬁcation can po-
tentially inﬂuence the biochemical activity and function of
the target protein. Recently, Sacher et al. (15) identiﬁed
the residues that serve as SUMO acceptor sites in Rad52.
In addition to the SUMO-conjugating enzyme Ubc9,
Rad52 modiﬁcation is stimulated by the SUMO ligase
Siz2 (15). SUMO was shown to protect Rad52 from
proteasomal degradation and to facilitate the exclusion
of Rad52 recombination foci from the nucleolus to
maintain a low level of recombinational repair at the ribo-
somal gene locus (16).
Here, we show that the SUMOylation of Rad52 is sig-
niﬁcantly stimulated in the presence of ssDNA in vitro.
We ﬁnd that enhanced SUMOylation is mediated via
the C-terminal DNA binding domain of Rad52 and
requires lysine K253. Moreover, we demonstrate that
SUMOylated Rad52 exhibits lower aﬃnity towards
ssDNA and dsDNA, and also has reduced single-strand
annealing activity. These data provide mechanistic infor-
mation regarding the role of SUMOylation in the regula-
tion of the biochemical activities of Rad52.
MATERIALS AND METHODS
Genetic methods, yeast strains and plasmids
Yeast strains were manipulated using standard genetic
techniques, and media were prepared as previously
described (17). All strains used in this study are RAD5
derivatives of W303 (Supplementary Table S1) (18,19).
To generate the (His)6-RAD52(N+M)::pET11d
plasmid, the (His)6-RAD52::pET11d plasmid was
digested with BamHI. The resulting DNA product was
isolated from agarose gel, ligated and sequenced. The
plasmids expressing the rad52 (K43,44R), rad52
(K253R) and rad52 (K43,44,253R) mutants were
constructed by site-directed mutagenesis using speciﬁc
primers (Supplementary Table S2). The amino acid num-
bering corresponds to translation from ﬁrst ATG of
GenBank accession number CAA86623 for Rad52
protein.
DNA substrates
Oligonucleotides were purchased from VBC Biotech.
The sequences of the oligonucleotides are shown in
Supplementary Table S2. Oligo-1 and Oligo-3 were
modiﬁed with ﬂuorescein at the 50 end. The DNA sub-
strates were prepared by mixing an equimolar amount
of the constituent oligonucleotides in the hybridization
buﬀer H (50mM Tris–HCl, pH 7.5, 100mM NaCl,
10mM MgCl2), heated at 90 C for 3min, and cooled
slowly to room temperature to allow DNA annealing.
The annealed DNA substrates were puriﬁed by fraction-
ation in a 1-ml Mono Q column (GE Healthcare Life
Sciences) with a 20-ml gradient of 50–1000mM NaCl in
10mM Tris–HCl, pH 7.5. Peak fractions were ﬁltered,
dialysed into 50mM Tris–HCl, pH 7.5, containing 5mM
MgCl2 and concentrated in a Vivaspin concentrator with a
5kDa cutoﬀ. The concentration of the DNA substrates
was determined by absorbance measurement at 260nm.
Recombinant protein expression and puriﬁcation
The various Rad52 species were expressed and puriﬁed
with modiﬁcations as described (5). Rad51 and RPA
proteins were puriﬁed as described (4,20).
Puriﬁcation of Aos1/Uba2 complex (E1 protein). The
Escherichia coli strain BL21(DE3) transformed with
plasmid for expression of E1 (Aos1/Uba2 complex)
protein (a kind gift from Dr B. Schulman) containing
GST-tagged Aos1 was induced with 0.5mM IPTG for
3h at 37 C. The cells were pelleted and stored at  80 C.
The cell pellet (7g) was resuspended in 25ml of cell
breakage buﬀer (CBB) (50mM Tris–HCl, pH 7.5, 10%
sucrose, 2mM EDTA) containing 150mM KCl, 0.01%
NP40, 1mM b-mercaptoethanol, sonicated and
centrifuged (100000g, 90min). Clariﬁed supernatant was
loaded onto 7-ml SP-sepharose column with its outlet con-
nected to a 7-ml Q-sepharose column (Amersham
Biosciences). Both columns were pre-equilibrated with
buﬀer K (20mM K2HPO4, 10% glycerol, 0.5mM
EDTA) containing 100mM KCl. The Q-sepharose
column was subsequently eluted with a 70-ml gradient of
100–800mM KCl in buﬀer K. Peak E1 protein fractions
eluting around 330–470mM KCl were pooled and mixed
with 800ml of GTH-sepharose (Amersham Biosciences)
washed in buﬀer K containing 100mM KCl for 1h at
4 C. The GTH-sepharose with bound proteins was
washed with 8ml of 100mM KCl in buﬀer K and eluted
in steps with 800ml of 10, 50, 100 or 200mM glutathione
(GTH) in buﬀer K containing 100mM KCl. The peak
fractions eluting within the range of 10–100mM GTH
were loaded onto a 0.5-ml Mono Q column followed by
elution using 5-ml gradient of 100–700mM KCl in buﬀer
K. The main fractions of E1 protein eluting from the
Mono Q column at  560mM KCl were concentrated in
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at  80 C.
Puriﬁcation of Ubc9 (E2 protein). The plasmid (a kind
gift from Dr Erica Johnson) expressing E2 (Ubc9)
protein containing (His)6-aﬃnity tag was introduced
into E. coli strain BL21(DE3). Overnight culture grown
at 37 Ci n2  TY medium was diluted 100-fold into
fresh 2 TY medium and incubated at 37 C. The
overexpression of E2 was induced by addition of 0.1mM
IPTG followed by an incubation at 25 C overnight.
To prepare cell extract, 13g of cell pellet was thawed
in 20ml of CBB containing 150mM KCl, 0.01%
NP40, 1mM b-mercaptoethanol and protease inhibitor
cocktail (pepstatin, leupeptin, aprotinin, chymostatin,
benzamidine and phenylmethylsulfonyl ﬂuoride). The
cells were disrupted by sonication and the crude extract
was clariﬁed by centrifugation (100000g,4  C, 90min).
The supernatant was passed through a 7-ml column of
Q-sepharose and the ﬂow-through fraction was applied
directly to a 7-ml SP-sepharose column that was eluted
with 70-ml gradient of 100–750mM KCl in buﬀer K. E2
protein eluted from SP-column at 290–370mM KCl. The
peak fractions were mixed with 750ml of Ni–NTA agarose
(Qiagen) for 75min at 4 C. The beads were washed with
7.5ml of buﬀer K containing 100mM KCl followed by a
7.5ml wash with buﬀer K containing 100mM KCl and
10mM imidazole. E2 protein was then eluted with buﬀer
K containing 100mM KCl and 50, 150 or 300mM imid-
azole, respectively. The fractions eluted from Ni–NTA
agarose column from 50 to 150mM imidazole were
pooled, applied onto a 1-ml Mono S column, and eluted
using a 10-ml gradient of 100–750mM KCl in buﬀer K.
E2 protein eluted at 360–510mM KCl was concentrated
to 20mg/ml in a Centricon-30 and stored in small aliquots
at  80 C.
Puriﬁcation of SUMO protein. The plasmid containing
the SUMO (Smt3) gene containing both (His)6-aﬃnity
and FLAG tags (a kind gift from Dr Erica Johnson)
was introduced into E. coli strain BL21(DE3). Overnight
culture grown in 2 TY medium at 37 C was diluted
100-fold into fresh medium and incubated at 37 C until
OD600 reached 0.8. At that time, IPTG was added to
0.5mM, and the culture was incubated at 37 C for 3h.
The cells were harvested by centrifugation and stored at
 80 C. Extract from 5g of cell paste was prepared by
sonication in 25ml of CBB containing 150mM KCl,
0.01% NP40, 1mM b-mercaptoethanol and protease
inhibitor cocktail. The lysate was clariﬁed by ultracentri-
fugation and the resulting supernatant was passed in
tandem over SP- and Q-sepharose columns (7ml each).
The Q-column was then eluted with a 70-ml gradient of
100–750mM KCl in buﬀer K. The SUMO-containing
fractions (370–470mM KCl) were pooled and mixed
with 600ml Ni–NTA agarose. The bead-bound proteins
were washed with 6ml of buﬀer K containing 100mM
KCl, followed by 6-ml of buﬀer K containing 100mM
KCl and 10mM imidazole. The bound proteins were
eluted with buﬀer K containing 50, 150, or 300mM imid-
azole and 100mM KCl. The fractions with SUMO protein
eluting from 50 to 300mM imidazole were pooled and
loaded onto a 0.5-ml Mono Q column and then eluted
with a 5-ml gradient of 100–900mM KCl in buﬀer K.
The peak fractions (400–700mM KCl) were pooled,
concentrated in a Centricon-30 to 10mg/ml and stored
at  80 C.
In vitro SUMOylation assay
The assay was performed in a 20ml reaction volume con-
taining 5.6mM of puriﬁed SUMO protein (Smt3), 400nM
E1 protein (Aos1/Uba2), 2.8mM E2 protein (Ubc9),
2.5mM ATP, buﬀer S (50mM HEPES, 100mM NaCl,
10mM MgCl2, 0.1mM DTT) and 2.7–4.1mM of various
Rad52 proteins. Reactions were incubated at 30 C for 3h,
stopped by addition of 30ml of SDS Laemmli buﬀer
(62.5mM Tris–HCl, 2% SDS, 5% b-mercaptoethanol,
10% glycerol, 0.002% bromphenol blue) and analysed
by SDS–PAGE and western blotting. The quantiﬁcation
of Rad52 SUMOylation was done using Quantity One
software (Bio-Rad) and is presented as a ratio of
mono-SUMOylated versus non-modiﬁed Rad52.
Circular dichroism spectroscopy
Circular dichroism (CD) spectra were recorded at 10 C
using a Jasco J-810 spectrometer (Jasco, Tokyo, Japan)
coupled with Peltier temperature controller. Data were
collected from 195 to 340nm, at 100nm/min, 1s
response time and 2nm bandwidth using a 0.1cm quartz
cuvette containing studied protein/DNA in 20mM phos-
phate buﬀer and 50mM KCl (pH 7.5). CD diﬀerence
spectrum was calculated by subtracting spectrum of
DNA from that of protein–DNA complex. Each
spectrum represents an average of 10 individual scans
and is corrected for absorbance caused by the buﬀer.
CD data were expressed in millidegrees (instrument units
of CD).
Electrophoretic mobility shift assay
Indicated amounts of various forms of Rad52 protein
were incubated with ﬂuorescently-labelled DNA sub-
strates (0.44mM nucleotides) at 37 Ci n1 0ml of buﬀer B
(50mM Tris–HCl, pH 7.8, 5mM MgCl2 and 1mM DTT)
for 10min. After the addition of gel loading buﬀer
(60% glycerol, 10mM Tris–HCl, pH 7.4 and 60mM
EDTA), the reaction mixtures were resolved in 7.5%
native polyacrylamide gels in TBE buﬀer (40mM Tris–
HCl, 20mM boric acid, 2mM EDTA, pH 7.5) at 4 C,
and the DNA species were quantiﬁed using Quantity
One software (Bio-Rad).
Single-strand annealing assay
The assay was essentially done as described previously
(14). Oligo-2 and ﬂuorescently labelled Oligo-1 (0.26mM
nucleotides) were incubated in separate tubes at 37 C for
3min in the absence or presence of RPA (20nM) in 20ml
of buﬀer D (40mM Tris–HCl, pH 7.5, 50mM KCl, 1mM
DTT and 100mg/ml bovine serum albumin (BSA)).
Varying amounts of Rad52 or Smt3-Rad52 were added
to the tube containing Oligo-2 and then mixed with
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for 8min. At the indicated times, 9ml of the annealing
reactions was removed and treated with 0.5% SDS, and
500mg/ml proteinase K at 37 C for 10min in a total
volume of 10ml. The individual samples were resolved in
12% native polyacrylamide gels run in TBE buﬀer. DNA
annealing was quantiﬁed as the portion of the
ﬂuorescently-labelled Oligo-1 that had been converted
into the double-stranded form.
Binding of Rad52 to Rad51 and RPA immobilized
on Aﬃ-gels
Aﬃ-gel 15 beads containing either Rad51 (Aﬃ-Rad51;
300ng/ml) or RPA (Aﬃ-RPA; 350ng/ml) were prepared
as described previously (21). Puriﬁed Rad52 or Smt3-
Rad52 were mixed with 30ml of Aﬃ-Rad51 or Aﬃ-RPA
in 25ml of buﬀer T (20mM Tris–HCl, pH 7.5, 150mM
KCl, 1mM DTT, 0.5mM EDTA and 0.01% NP40)for
30min at 4 C. The beads were washed twice with 100ml
of buﬀer T before being treated with 30ml of SDS
Laemmli buﬀer to elute bound proteins. The supernatant
that contained unbound Rad52 or Smt3-Rad52 protein,
and the SDS eluate (10ml each) were analysed by SDS–
PAGE in 10% gel.
Gel ﬁltration
A Sephacryl S400 column (25ml total) was used to
monitor the oligomeric status of Rad52 and
SUMOylated Rad52 proteins. The proteins were ﬁltered
through the sizing column at 0.1ml/min in buﬀer
Kcontaining 200mM KCl, collecting 0.5ml fractions.
The indicated column fractions were separated by SDS–
PAGE electrophoresis to determine contents of the
Rad52, or SUMOylated Rad52 proteins, respectively.
Determination of mitotic recombination rates
Interchromosomal and direct-repeat recombination
between non-functional leu2 heteroalleles was measured
as described (22), except that the single colonies were
inoculated into liquid SC medium containing 100mg/ml
adenine. The plating eﬃciency and the number of recom-
binants were determined by plating an appropriate
number of cells on SC and SC-Leu medium. After
3 days at 30 C, the number of colonies was counted.
The Leu
+ colonies were replica-plated to SC-Leu-Ura in
order to distinguish between gene conversion (Ura
+) and
single-strand annealing (Ura
 ) events in the direct-repeat
assay. For each strain, 15–19 independent trials were
carried out. The corresponding recombination rates and
their standard deviations were calculated according to the
median method (23). The rate of ADE2 marker loss at the
rDNA was determined as described (24). In brief, single
colonies were grown overnight in liquid YPD medium at
30 C. Then, cultures grown to exponential phase were
diluted before plating an appropriate number of cells on
YPD. After 3 days at 30 C, the number of half-sectored
red–white colonies was counted as a direct measure of the
rDNA recombination rate.
Analysis of meiotic recombination
Sporulation was induced by replica-plating of the fresh
patch of cells from solid YPD to SPO medium and
followed by incubation at 30 C for 3 days. Next, cells
were resuspended in H2O and inspected microscopically
to determine the sporulation eﬃciency. For each strain,
18 four-spore tetrads were dissected to determine the
germination eﬃciency. To determine the meiotic recom-
bination frequency and relative viability, OD600 was
measured and cells were sonicated before plating an
appropriate number of cells on SC and SC-Leu medium.
Analysis of inverted-repeat substrate recombination and
break-induced replication
Recombination between inverted repeats was assayed
using the ade2-50::TRP1::ade2-n system (provided by
L. Symington, Columbia University, New York, NY,
USA). The experiments were essentially performed as
described (23). A chromosome fragmentation assay was
used to measure the eﬃciency of break-induced replication
(BIR) in Rad52 SUMOylation-defective mutant. The
experiments were performed as previously described (25).
Microscopy
Cells were processed for ﬂuorescence microscopy as
described previously (26). Yellow ﬂuorescent protein
(YFP) was visualized using a band-pass YFP (Cat.
no. 41028) ﬁlter set from Chroma (Brattleboro, VT,
USA). Images were acquired with a 10% neutral density
ﬁlter in place to reduce photobleaching and phototoxicity.
Fluorescence intensities were measured in arbitrary units
(AU) using Volocity software (Improvision).
Results
Enhancement of Rad52 SUMOylation by ssDNA
Previous studies have shown that Rad52 protein is
SUMOylated at lysines K43, K44 and K253 in response
to DNA damage [Figure 1A, (15)]. To deﬁne the biochem-
ical requirements of this reaction, we have established an
in vitro SUMOylation assay using puriﬁed yeast Ubc9,
Aos1, Uba2 and Smt3 (SUMO in yeast) proteins
(Figure 1B and Supplementary Figure S3). Addition of
Rad52 protein to this reaction resulted in its modiﬁcation
(Figure 2A). We have also conﬁrmed that lysines K43, 44
and 253 are the major in vitro SUMO conjugation sites as
observed in vivo [(15), Supplementary Table S3)]. Since
Rad52 is known to bind both ssDNA and dsDNA, we
decided to assess the eﬀect of DNA on Rad52
SUMOylation. Importantly, when the SUMOylation of
Rad52 was performed in the presence of ssDNA
cofactor, we noticed a signiﬁcant stimulation of the
SUMO modiﬁcation ( 3-fold, Figure 2A). That Rad52
was modiﬁed by SUMO conjugation was conﬁrmed by
immunoblotting with anti–Smt3 and anti–Rad52
antibodies (Figure 2B and C). In contrast, the addition
of dsDNA did not enhance the level of SUMOylated
Rad52 species (Figure 2A), suggesting that only ssDNA
binding confers this stimulation. Interestingly,
Nucleic Acids Research, 2010,Vol.38, No. 14 4711experiments with titration of ssDNA showed that stimu-
lation of Rad52 SUMOylation was optimal when the ratio
of Rad52 to nucleotides reached approximate ratio 1:37
(Figure 2D and E). This is in good correlation with pre-
viously published data indicating that Rad52 protein
binds  36nt of ssDNA (27). Maximum stimulation cor-
responded up to 25% of modiﬁed Rad52 protein.
Altogether these data show that: (i) Rad52 can be
SUMOylated in vitro, (ii) the pattern of SUMOylation is
identical to that observed in vivo and (iii) Rad52 binding
to ssDNA stimulates its SUMOylation.
Binding of ssDNA causes a conformational change
in Rad52
Stimulation of Rad52 SUMOylation by ssDNA prompted
us to test whether ssDNA binding could cause conform-
ational changes in the Rad52 protein. Therefore, we
measured and compared CD spectrum of Rad52 alone
and diﬀerence spectrum of Rad52 in the presence of
DNA (Figure 2F; red and green squares, respectively).
The results provided evidence that interaction of Rad52
protein with ssDNA induced a conformational change in
the protein. This conformational change takes place
without any alteration in the structure of the DNA,
since the DNA spectrum did not change above 240nm.
We attribute the increased magnitude of the negative
bands to an increase in the a-helicity of Rad52 (28). In
summary, binding of ssDNA results in a conformational
change within Rad52 equivalent to an increase in the
a-helicity.
ssDNA bound by RPA but not by Rad51 can stimulate
SUMOylation of Rad52
The ssDNA generated during DSB repair is often pro-
tected by interaction with other ssDNA binding
proteins, namely RPA and Rad51. Therefore, we tested
if RPA- or Rad51-bound ssDNA is still accessible for
interaction with Rad52 and whether it enhances Rad52
SUMOylation. We pre-incubated ssDNA with increasing
amounts of RPA protein and examined the eﬀect of
RPA on Rad52 SUMOylation in vitro. Under the experi-
mental conditions, RPA bound eﬃciently to ssDNA
(Supplementary Figure S4) with stoichiometry of one
RPA trimer per up to 30nt. As shown in Figure 3A and
B, the level of stimulation was similar to that without
RPA, suggesting that ssDNA coated with RPA can
enhance Rad52 SUMOylation. Even with a 2-fold molar
excess of RPA over the ssDNA (Figure 3A, lane 8), stimu-
lation of Rad52 SUMOylation is comparable to that
observed with ssDNA (Figure 3A, lane 3). Next, we
pre-incubated ssDNA with increasing amounts of Rad51
protein to form presynaptic ﬁlaments. Notably, this DNA
was no longer accessible for Rad52 and resulted in
decreased Rad52 SUMOylation to the basal level
observed in the absence of ssDNA (Figure 3C and D).
Figure 1. Puriﬁcation of Rad52 species and SUMO machinery proteins. (A) Schematic representation of functional domain within S. cerevisiae
Rad52 protein, including the positions of known SUMO acceptor lysines. The RPA interaction domain (black box, residues 308–311) and Rad51
interaction domain (grey box, residues 409–412) are indicated. (B) Puriﬁed SUMO machinery proteins: GST-tagged Aos1/Uba2 heterodimer (1mg),
(His)6-tagged Ubc9 and Smt3 proteins (1mg each) were run on a 15% SDS–PAGE and stained with Coomassie blue. (C) Puriﬁed (His)6-tagged
Rad52 species (1mg each): Rad52, Rad52 (K43,44R), Rad52 (K253R) and Rad52 (K43,44,253R) were run on a 10% SDS–PAGE and stained with
Coomassie blue.
4712 Nucleic Acids Research, 2010,Vol.38, No. 14Speciﬁcally, the maximum inhibition of Rad52
SUMOylation occurred at 3nt of ssDNA per Rad51
monomer, corresponding to the ssDNA binding site size
of Rad51 and ensuring fully coated DNA (20). Further
increasing the Rad51 amount did not have any additional
eﬀect on Rad52 SUMOylation (Figure 3C, lane 10 and
data not shown). Taken together, these data indicate
that ssDNA bound by RPA is fully accessible for
binding by Rad52, whereas the DNA in a Rad51 nucleo-
protein ﬁlament is not.
Figure 2. In vitro SUMOylation of Rad52 is stimulated by ssDNA. (A) The eﬀect of ssDNA and dsDNA on Rad52 SUMOylation. In vitro
SUMOylation assays were performed with recombinant Aos1/Uba2 (400nM), Ubc9 (2.8mM) and Smt3 (5.6mM) in the presence or absence of
ATP (2.5mM), Rad52 (2.7mM), 83-mer ss-DNA (100mM nucleotides) or dsDNA as indicated. The reaction mixtures were incubated for 3h at 30 C,
stopped by adding 30ml of SDS Laemmli buﬀer and analysed on 7% SDS–PAGE followed by silver staining. The hash symbol indicates high
molecular poly-SUMOylated species of Rad52 and E1. The number at the bottom of the gel represents the ratio of modiﬁed and unmodiﬁed Rad52.
SUMOylated Rad52 protein was conﬁrmed by western blotting using anti-Smt3 (B) or anti-Rad52 (C) antibodies. (D) In vitro SUMOylation assay
on Rad52 protein carried out without DNA (lanes 1 and 2) or with increasing amount of 83-mer ssDNA (15, 50, 100, 150, 300mM nucleotides; lanes
3–7). The hash symbol indicates high molecular weight SUMOylated species. (E) Graphical representation of the gel in panel D, as a ratio of
mono-SUMOylated versus non-modiﬁed Rad52. (F) The CD spectrum of 83-mer ssDNA (black), Rad52 (red) and the Rad52-ssDNA complex
(white). The diﬀerence spectrum (green) represents values for Rad52 in the complex with DNA from which the spectrum of DNA has been
subtracted. To form the complex, protein and DNA were incubated together for 10min at 37 C prior to the analysis. The concentration of the
protein was 3.87mM and the concentration of DNA was 2.24mM. The samples were measured at 10 C in 20mM phosphate buﬀer containing
50mM KCl, pH 7.5.
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K253 is mediated via the C-terminal DNA binding domain
Rad52 SUMOylation occurs at three lysine residues:
K43, K44 and K253 (15), so we constructed and puriﬁed
Rad52 mutant proteins lacking one or more of these
SUMO-conjugation sites for the in vitro studies
(Figure 1C). Interestingly, the Rad52 (K43,44R) mutant
showed a pattern of SUMOylation similar to wild-type
Rad52 both in the absence and presence of ssDNA
(Figure 4A), suggesting that ssDNA-enhanced
SUMOylation can occur at K253 alone. The other two
Rad52 mutant proteins containing the K253R mutation
[Rad52 (K253R) and Rad52 (K43,44,253R)] are strongly
impaired for Rad52 SUMOylation (Figure 4A), indicating
that residues K43 and K44 are modiﬁed as a consequence
of SUMOylation at lysine 253 (Figure 4A). This is diﬀer-
ent to previously published data which could reﬂect the
presence of E3 ligase in the in vivo situation (15). To help
eliminate the possibility that the individual mutations
could aﬀect the protein folding, we tested all our mutant
proteins for DNA binding and DNA strand annealing,
and found no diﬀerence between wild-type and mutant
proteins (Supplementary Figure S1).
Rad52 was shown to harbour two DNA binding
domains, one at the amino-terminus and the other at its
carboxyl-terminus [Figure 1A, (5)]. We wished to examine
which of these domains are responsible for enhancement
of Rad52 SUMOylation. Since this stimulation is
mediated via K253, located at the middle region of
Rad52, we checked the SUMOylation status and its
enhancement after ssDNA binding using three Rad52
fragments that harbour either the amino-terminus and
the middle portion of the protein (N+M), the middle
portion only (M) or both the middle portion and
carboxyl-terminus (M+C). Even though all three frag-
ments can be SUMOylated in vitro, only the reaction
involving Rad52 (M+C) was stimulated by ssDNA
(Figure 4B), suggesting that the C-terminal binding
region is responsible for the SUMOylation enhancement.
SUMOylation attenuates DNA binding and
strand annealing
The eﬀect of ssDNA on SUMOylation eﬃciency
prompted us to test the biochemical properties of
SUMOylated Rad52 protein. The oligomeric status of
Rad52 prevents puriﬁcation of the SUMOylated fraction
from the in vitro SUMOylation reaction. Therefore, the
SUMOylation reaction was performed in the presence or
absence of ATP to ensure the same quantity of Rad52 for
individual experiments, leading to up to 10% of modiﬁed
Rad52. First, we tested both free and SUMOylated Rad52
for its ability to bind DNA using a well-established elec-
trophoretic mobility shift assay. The SUMOylated Rad52
showed a signiﬁcant decrease in DNA binding eﬃciency
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Figure 3. Eﬀect of accessibility of RPA- or Rad51-coated ssDNA on Rad52 SUMOylation. (A) RPA bound to ssDNA does not aﬀect Rad52
SUMOylation. Increasing amounts of RPA protein (1.2, 3.5, 4.6, 5.9 and 8.3mM) were pre-incubated with 83-mer ssDNA (100mM nucleotides) for
10min at 37 C and then mixed with E1 (400nM), E2 (2.8mM), Smt3 (5.6mM), Rad52 (2.7mM) and 2.5mM ATP. After 3h incubation at 30 C, the
reactions were analysed by 7.5% SDS–PAGE and silver-stained. (B) The ratio of mono-SUMOylated versus non-modiﬁed Rad52 is presented by
quantifying the corresponding bands in (A). (C) Rad51-coated ssDNA does not stimulate Rad52 SUMOylation. The reactions were carried out as in
(A) except increasing amounts of Rad51 were used (3, 7, 14, 21, 27, 34, 41mM). The reaction mixtures were stopped and analysed by 10% SDS–
PAGE followed by silver staining. (D) Quantiﬁcation of Rad52-Smt3 conjugate from C, as a ratio of mono-SUMOylated versus non-modiﬁed
Rad52. The arrow indicates amount of Rad51 that fully coats ssDNA. The hash symbol indicates high molecular poly-SUMO chains of Rad52 and
E1 proteins.
4714 Nucleic Acids Research, 2010,Vol.38, No. 14towards both ssDNA and dsDNA (Figure 5A and B, and
data not shown). Next, we addressed whether the lower
aﬃnity towards DNA can also aﬀect the annealing
activity of Rad52 protein. Both unmodiﬁed and
SUMOylated Rad52 were incubated with complementary
ssDNA strands, and their annealing ability was moni-
tored. Importantly, SUMOylated Rad52 showed a
lower activity in the annealing reaction (Supplementary
Figure S2). This has been further conﬁrmed in the
reaction when ssDNA is coated by RPA to reﬂect the
in vivo conditions and to prevent the eﬀect of possible
DNA self-annealing (Figure 5C and D). No eﬀect of com-
ponents of the SUMOylation reaction or ATP alone on
DNA binding or single-strand annealing activity was
observed (data not shown). In summary, SUMOylation
of as little as 10% of the total Rad52 protein is suﬃcient
Figure 5. Rad52 SUMOylation aﬀects its biochemical activities. (A) SUMOylation of Rad52 inhibits its binding to DNA. Increasing amounts of
Rad52 or Smt3-Rad52 (20, 40, 80, 200nM) were incubated with ﬂuorescently labelled 49-mer ssDNA (0.49mM nucleotides) at 37 C for 10min. The
reaction mixtures were resolved in 7.5% native polyacrylamide gels, and the DNA species were quantiﬁed using Quantity One software (Bio-Rad).
(B) The results from (A) plotted. (C) SUMOylation of Rad52 inhibits its strand annealing activity. Labelled Oligo-1 (0.25mM nucleotides) and
Oligo-2 (0.25mM nucleotides) were incubated separately with RPA (20nM) for 3min at 37 C. The annealing reactions were initiated by mixing
RPA-coated oligonucleotides and Rad52 or Smt3-Rad52 proteins (0.7, 5, 10, 20nM) and incubated at 37 C. After 8min of incubation, 9ml of the
annealing reactions was removed and treated with 0.5% SDS, and 500mg/ml proteinase K at 37 C for 10min. The reaction mixtures were resolved in
12% native polyacrylamide gels. (D) The averaged values of results from three independent experiments are plotted.
Figure 4. Binding of Rad52 to ssDNA via C-terminal domain enhances the SUMOylation of lysine K253. (A) SUMOylation at lysine K253 is
stimulated by ssDNA. The standard in vitro SUMOylation reaction was done with wild-type Rad52 (2.7mM) or SUMO-deﬁcient acceptor lysine
Rad52 mutants: Rad52 (K43,44R), Rad52 (K253R) and Rad52 (K43,44,253R). (B) The C-terminal DNA binding domain of Rad52 is responsible for
stimulation of SUMOylation. Rad52 protein and its fragments: Rad52 (N+M) (4.13mM), Rad52 (M) containing GST-tag (3.52mM) and Rad52
(M+C) (4.03mM) were SUMOylated in vitro in the presence or absence of 83-mer ssDNA (100mM nucleotides) and analysed. The asterisks indicate
main SUMOylated Rad52 species. The hash symbol indicates high molecular poly-SUMO chains of Rad52 and E1 proteins.
Nucleic Acids Research, 2010,Vol.38, No. 14 4715to signiﬁcantly decrease Rad52 aﬃnity towards both
ssDNA and dsDNA and decrease single-strand annealing
activity.
SUMOylation of Rad52 does not aﬀect its interactions
with Rad51 and RPA
Rad52 is known to self-associate (8) and interact with
other HR proteins including Rad51 (10,11) and RPA
proteins (12,29,30). We have tested the eﬀect of Rad52
SUMOylation on these interactions. Since Smt3 protein
in this experiment contains the FLAG tag, we ﬁrst
assayed the Rad52 oligomerization status on anti-FLAG
agarose beads. As shown in Figure 6A, the ratio of
modiﬁed versus unmodiﬁed Rad52 protein does not
change after anti-FLAG pull-down. This was further con-
ﬁrmed by size exclusion chromatography (Sephacryl S400,
see ‘Materials and Methods’ section), which showed that
SUMOylation has little or no eﬀect on the oligomeric state
of Rad52 (Figure 6B). In summary, the oligomeric state of
Rad52 is not aﬀected upon SUMOylation. Moreover,
SUMO conjugation occurs to the same degree among
the individual Rad52 oligomers (Figure 6A and B).
Figure 6. Rad52 oligomerization and interaction with RPA and Rad51 are not aﬀected by its SUMOylation. (A) SUMOylation of Rad52 does not
inﬂuence its oligomerization status. Rad52 and Smt3-Rad52 (2.3mM) in 40ml of buﬀer S were incubated with 4ml of anti-FLAG agarose in 10mlo f
buﬀer T containing 200mM KCl for 30min at 4 C. The beads were washed and treated with 25ml of SDS Laemmli buﬀer to elute bound proteins.
The supernatant (S) that contained unbound Rad52 or Smt3-Rad52 protein, wash (W) and the SDS eluate (E) (10ml each) were analysed on 12% gel
SDS–PAGE followed by staining with Coomassie Blue. The arrows and symbol hash denote anti-FLAG IgG and higher order SUMOylated species,
respectively. (B) Analysis of Rad52 oligomerization status by gel ﬁltration. Puriﬁed Rad52 or Smt3-Rad52 proteins (9mM) in 200ml of buﬀer S were
ﬁltered through a sephacryl S400 column. The indicated fractions were run on 10% SDS–PAGE followed by staining with Coomassie blue. The
elution positions of the size markers are indicated: TG, thyroglobulin (669kDa) and CAT, catalase (223kDa). (C) SUMOylation of Rad52
does not aﬀect its interaction with Rad51. Puriﬁed Rad52(M+C) or Smt3-Rad52(M+C) (22mM) were mixed with Aﬃ-Rad51 beads (4,6mM
Rad51) in 25ml of buﬀer K and incubated for 30min at 4 C. The beads were washed and treated with 25ml of SDS Laemmli buﬀer to elute
bound proteins. The supernatant that contained unbound Rad52 or Smt3-Rad52 protein, wash, and the SDS eluate (5ml each) were analysed by
SDS–PAGE in 12% gel followed by western blotting using anti-Rad52 antibody. (D) SUMOylation of Rad52 does not aﬀect its interaction with
RPA. The interaction with RPA was tested using puriﬁed Rad52 (M) or Smt3-Rad52 (M) (230pmol) and Aﬃ-RPA (1mM RPA) beads pre-incubated
with ssDNA (1mgo fTX174) for 10min at 37 C. Both mixtures were combined in 45ml of buﬀer Tfollowed by an incubation for 30min at 4 C and
then analysed as in panel C.
4716 Nucleic Acids Research, 2010,Vol.38, No. 14However, we cannot exclude the possibility that
SUMOylated and unmodiﬁed subunits re-distributed
during the SUMOylation and pull-down assays. Electron
microscopy of unmodiﬁed and SUMOylated Rad52 also
revealed no diﬀerence in the oligomeric status of Rad52
(data not shown).
Next, we checked the ability of SUMOylated Rad52 to
interact with Rad51. For this purpose, we generated
Aﬃ-Rad51 beads to use as aﬃnity matrix for testing inter-
action with unmodiﬁed and modiﬁed Rad52. We used a
Rad52 fragment without the N-terminal oligomerization
domain [Rad52 (M+C)] to minimize its eﬀect on the role
of SUMOylation on Rad51 interaction. The result from
this experiment showed SUMOylated Rad52 is just as
capable of Rad51 association as the unmodiﬁed protein
(Figure 6C). To test the interaction with RPA, we
generated Aﬃ-RPA beads and performed a pull-down
assay as described previously (5). Rad52 (M) fragment
missing the N- and C-terminal DNA binding domains
was used to monitor its ability to interact with
DNA-bound RPA (5). Little or no change could be
observed between Rad52 (M) and SUMOylated Rad52
(M) for RPA association (Figure 6D). Taken together,
the above results allowed us to conclude that
SUMOylation does not aﬀect Rad52 self-association or
its interaction with Rad51 and RPA.
Rad52 SUMOylation regulates recombination in vivo
To address the eﬀects of Rad52 SUMOylation in vivo,w e
examined the SUMO-deﬁcient mutants (rad52-K43,44R,
-K253R or -K43,44,253R) using several recombination
assays. In agreement with previous work (15), we found
that these mutations did not dramatically aﬀect the rate of
intra- or inter-chromosomal recombination during mitosis
(Tables 1 and 2), but caused a shift from single-stranded
annealing to gene conversion events (Table 1). In addition,
these mutations resulted in slight hyper-recombination
phenotype in rDNA recombination [Table 3, (16)].
We also expanded the previous studies and examined
the eﬀect of rad52 SUMOylation mutants in additional
mitotic and meiotic recombination assays. We found
that rad52-K43,44,253R exhibited 60% of a wild-type
level of BIR (Table 4), suggesting that Rad52
SUMOylation contributes positively to this type of recom-
bination. In meiosis, although all three rad52 SUMO
mutants exhibited wild-type levels of recombination
at the leu2 locus (Table 5), rad52-K43,44,253R, but
not rad52-K43,44R and rad52-K253R cells exhibited
Table 1. Eﬀect of rad52 SUMOylation-defective mutants on mitotic heteroallelic and direct-repeat recombination
Genotype Heteroallelic
recombination
rate ( 10
 8)
a
Fold change
relative
to wild-type
b
Direct-repeat
recombination ( 10
 6)
a
Fold change
relative
to wild-type
P-value
(direct-repeat)
c
Fraction
Ura
+ GC
P-value
(Ura
+)
d
RAD52 219±29 1 51±8 1 n.a. 0.33 n.a.
rad52D 0.7±0.4 0.005 2.3±0.5 0.03 <0.001 0.0004 <0.001
K43,44R 253±48 1.2 107±15 2.1 0.06 0.45 <0.001
K253R 179±30 0.8 70±11 1.4 0.13 0.37 0.075
K43,44,253R 216±36 1.0 74±11 1.4 0.16 0.40 <0.001
aRecombination rate is presented as events per cell per generation as described previously (37). For each strain, 15–19 trials were performed. Strains
ML412 (wild-type), ML414 (rad52D), ML466 (rad52-K43,44R), ML467 (rad52-K253R), ML480 (rad52-K43,44,253R).
bThere is no signiﬁcant diﬀerence in mitotic heteroallelic recombination between wild-type and the SUMOylation defective rad52 mutants.
cP-value for t-test applied to the direct-repeat recombination rate relative to wild-type.
dP-value for Pearson’s  
2 test relative to wild-type.
Schematic of the assays for spontaneous heteroallelic (i) and direct-repeat (ii) recombination between leu2-DEcoRI and leu2-DBstEII heteroalleles.
Nucleic Acids Research, 2010,Vol.38, No. 14 4717Table 4. Eﬀect of rad52-K43,44,253R mutation on the frequency of break-induced replication
a
Genotype Frequency of stable Ura
+ ( 10
 2)
with CFV/D8B-tg
P-value ( 
2)
b Fold change relative
to wild-type
RAD52 3.94±0.75 n.a. 1
rad52D <0.0002 n.d. <0.0039
K43,44,253R 2.39±0.44 0.0044 0.60
aThe frequency of break-induced replication is the number of stable Ura
+ transformants per microgram with cut DNA divided
by the number of transformants per microgram with uncut DNA transformed, as described previously (25). For each genotype,
ﬁve to seven trials were performed.
bThe  
2-test was applied to compare the recombination rate with that of the wild-type strain.
Schematic of the assay for BIR resulting in a stable Ura
+ recombinant strain with the CFV/D8B-tg fragment.
Table 2. Eﬀect of rad52-K43,44,253R on recombination rates of the
inverted-repeat substrate
a
Genotype Rates (10
 8)
a P-value
( 
2)
b
Fold
change
relative to
wild-type
WT 28432±4982 n.a. 1.00
rad52D 5±1.4 n.d 0.0002
rad51D 5631±1358 n.a. 0.20
rad51D, rad52D 0 0.002 <0.00004
rad51D, rad52K43,44,253R 4986±1617 0.31 0.18
aRates are per cell per generation as described previously (38). Results
presented are a mean of 3–5 independentisolates for each genotype, out
of a single representative experiments.
bThe  
2-test was applied to compare the recombination rates with that
of rad51D strain.
Schematic of the assay for spontaneous inverted-repeat recombination
between ade2-50D and ade2-DNdeI heteroalleles.
Table 3. Eﬀect of rad52 SUMOylation-defective mutants on rDNA
recombination
Genotype ADE2 loss
a Fold
change
relative to
wild-type
Rate of
loss
( 10
 3)
P-value
b Half-sectored/
total
RAD52 2.89 n.a. 112/38700 1
rad52D 0.85 <0.001 17/20029 0.29
K43,44R 3.71 0.095 79/21279 1.28
K253R 3.95 0.036 84/21271 1.36
K43,44,253R 9.51 <0.001 380/39939 3.29
arDNA recombination in the ﬁrst generation after plating was assayed
by counting half-sectored colonies as described previously (24).
Recombination was assayed in strains RMY180-5A (wild-type),
NEB136-2B (rad52D), NEB187-10A (rad52-K43,44R), NEB168-11B
(rad52-K253R), NEB63-2B (rad52-K43,44,253R).
bFisher’s exact test was applied to compare the recombination rate with
that of the wild-type strain.
Schematic of the assay for spontaneous rDNA recombination resulting
in ADE2 marker loss.
4718 Nucleic Acids Research, 2010,Vol.38, No. 14increased spore viability. This eﬀect is not due to an alter-
ation of the ability of these mutant proteins to bind
ssDNA or dsDNA or to anneal complementary DNA,
because Rad52-K43,44,253R, Rad52-K43,44R and
Rad52-K253R proteins exhibit wild-type levels of
activities in these reactions in vitro (Supplementary
Figure S1). Thus, the eﬀect on spore viability could be
due to the fact that SUMOylation of Rad52 aﬀects
other meiotic events. Taken together, these results
suggest that Rad52 SUMOylation facilitates certain re-
combination sub-pathways and disfavours the others
and may contribute to meiotic processes that determine
spore viability.
Finally, we also tested the in vivo localization of a
Rad52 SUMO-deﬁcient mutant by cytological analysis.
The fusion of wild-type as well as the Rad52-
K43,44,253R proteins to YFP revealed that the mutant
protein forms foci similarly to wild-type, but the
duration of the foci is signiﬁcantly shorter (P=0.01,
t-test) (Figure 7A and B). The average intensity of the
YFP signal for wild-type and the SUMO-deﬁcient
mutant foci is similar, suggesting that the diﬀerence in
duration of foci is not due to a diﬀerence in the amount
of proteins (data not shown).
DISCUSSION
HR is essential for genome maintenance and must be
tightly controlled to avoid of loss of heterozygosity,
chromosome translocations and gene deletions (1,3).
Recent studies have documented several examples of HR
proteins and associated factors being post-translationally
modiﬁed by the SUMO protein. In particular, defects in
SUMOylation of Rad52, Rad59 and RPA result in
genomic context-dependent changes in HR and chromo-
somal rearrangements (31). Also, during S-phase, Srs2
Figure 7. Rad52-K43,44,253R foci exhibits shorter duration than wild-type. Time-lapse of spontaneous wild-type Rad52 and mutant
Rad52-K43,44,253R foci. Strains W5094-1C (RAD52-YFP) and ML228 (rad52-K43,44,253R-YFP) were examined by ﬂuorescence microscopy at
5min intervals as described in the ‘Materials and Methods’ section. (A) Representative examples of time-lapse image sequences. Arrowheads mark
Rad52 foci. (B) Quantitative analysis of time-lapse analysis. The number of cell cycles analysed is n=173 for wild-type Rad52 and n=252 for the
Rad52-K43,44,253R mutant protein. The class of cells for which no foci were observed amounted to 62 and 63% for RAD52 and rad52-K43,44,253R,
respectively (not shown in the graph).
Table 5. Eﬀect of rad52 SUMOylation-defective mutants on meiotic recombination
Genotype Meiotic recombination
frequency ( 10
 4)
a
Fold change relative to
wild-type
Sporulation
eﬃciency
b,%
Germination
eﬃciency
c,%
Relative
viability
d
RAD52 118±31 1 41 96 1
rad52D 0.06±0.06 0.001 1 n.a. 0.10
K43,44R 144±38 1.2 58 69 0.95
K253R 77±24 0.7 55 88 0.84
K43,44,253R 109±27 0.9 53 96 2.39
aRecombination frequency is presented as events per colony forming unit. For each strain, three trials were performed. Strains ML412 (wild type),
ML414 (rad52D), ML466 (rad52-K43,44R), ML467 (rad52-K253R), ML480 (rad52-K43,44,253R) were sporulated on solid medium at 30 C essentially
as described previously (39). [See schematic in Table 1(i)].
bSporulation eﬃciency was determined as the fraction of three to four spore tetrads out of all cells after 3 days on solid SPO medium at 30 C.
cGermination eﬃciency was determined by tetrad dissection of four-spore tetrads after 3 days on solid SPO medium at 30 C.
dViability is the number of colony forming units per milliliter per OD600 after sporulated on solid medium at 30 C.
Nucleic Acids Research, 2010,Vol.38, No. 14 4719(a helicase that blocks recombinational repair by disrupt-
ing Rad51 nucleoprotein ﬁlaments) is recruited to replica-
tion forks via interaction with SUMOylated PCNA
(proliferating cell nuclear antigen), thereby preventing
assembly of Rad51 nucleoprotein ﬁlaments on ssDNA
associated with the replication forks (32).
In this study we have strived to determine the eﬀects
of SUMOylation on the Rad52 protein. Using in vitro
biochemical assays, we have found that Rad52 is
SUMOylated in a manner that is stimulated by ssDNA
and dependent on the carboxyl-terminal DNA binding
domain. The stimulation is speciﬁc for ssDNA, as
dsDNA has no eﬀect on the level of SUMOylation. In
addition, the CD analysis revealed that binding of
ssDNA by Rad52 is accompanied by a conformational
change. By replacing each of the SUMOylation-targeted
lysines with arginine, we observed that increasing
SUMOylation in the presence of ssDNA is directed to
residue K253. In addition, we have found that RPA-
bound, but not Rad51-bound, ssDNA promotes Rad52
SUMOylation, suggesting that Rad52 SUMOylation is
favoured prior to the formation of Rad51 nucleoprotein
ﬁlament during HR in cells. Signiﬁcantly, while Rad52
SUMOylation has no eﬀect on its oligomerization and
interaction with RPA and Rad51, a small percentage
(<10%) of SUMOylated Rad52 markedly decreases its
aﬃnity to ssDNA and dsDNA, and causes a reduction
of its DNA annealing activity.
Collectively, our biochemical results suggest that upon
binding to resected ssDNA tails coated with RPA, Rad52
undergoes conformational change that can promote its
eﬃcient SUMOylation. Because SUMOylation does not
aﬀect Rad52 interaction with RPA and Rad51 or its oligo-
merization, this modiﬁcation does not appear to function
by altering protein–protein interactions. Instead, our
results suggest that SUMOylation attenuates Rad52
strand annealing activity and prompts its disassociation
from DNA. This can provide a mechanism either for fa-
vouring appropriate pathways over others or for dynamic
exchange of Rad52 on DNA. Consistently with previous
reports (15,16), we ﬁnd that SUMOylation of Rad52
in vivo suppresses rDNA recombination and favours
single-strand annealing over gene conversion in direct
repeat recombination at the LEU2 locus. In addition, we
show that both the N-terminal (K43,44) and central
(K253) SUMOylation sites contribute to these eﬀects.
Further, we show in this study that Rad52
SUMOylation reduces meiotic spore viability and
appears to favour BIR events. While the mechanism for
these eﬀects remains to be determined, it may reﬂect a
requirement of Rad52 dynamics in these pathways or a
role of SUMO in facilitating events unique to these
pathways.
Finally, it is noteworthy that the eﬀects of SUMO on
Rad52 activity are somewhat reminiscent of that on
thymine-DNA glycosylase, SUMOylation of which
induce its dissociation from the abasic site (33).
However, diﬀerent from thymine-DNA glycosylase,
Rad52 functions in concert with several additional
mediator and recombination proteins, such that its regu-
lation is more complex and defects in any single form of
regulation can be buﬀered by other mechanisms. Our
in vivo results suggest that this is likely the case, as the
lack of Rad52 SUMOylation does not dramatically aﬀect
several mitotic or meiotic recombination processes
examined here. However, the observed alteration of
recombination pathway usage as well as the changes
of duration times of recombination foci in rad52
SUMOylation defective mutants indicate the modiﬁcation
of Rad52 can indeed inﬂuence recombination pathway
choice or eﬃciency. An intriguing possibility is that
SUMOylation, in conjunction with other Rad52 functions
such as antagonizing Srs2 (34,35), helps to ﬁne-tune the
eﬃciency of recombinational repair. In addition, as other
recombination proteins and Rad52-interacting factors are
also subject to SUMOylation, the presence and modiﬁca-
tion of these factors may collectively provide a quality
control mechanism to direct HR pathway choice depend-
ing on substrate types and the chromosomal environment
(36). This work brings initial characterization of the role
of SUMOylation during HR; additional studies will need
to further our understanding of the underlying molecular
mechanism.
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